However, there are inconsistencies in the impacts of GDF11 analogues on liver diseases which might be due to diversity in GDF11 dosage or the methods used for increasing GDF11 (such as recombinant GDF11 or GDF11 overexpression by plasmid or viral vectors).33, 35. This evidence concerns the gene GDF11 and liver disorder.